Cindy Kosinski Email & Phone Number

California, United States

Sunnyvale, California, US

• Served as a subject matter expert for 23andMe’s health reports and features, providing scientific leadership in product development and regulatory strategy.
• Managed the development of genetic health reports under a design control quality system, including curating genetic associations to support clinical validity, creating content, coordinating document review, and writing.
• Led the scientific efforts for several FDA submissions for the 23andMe Personal Genome Service (PGS) Pharmacogenetics Reports, including authoring labeling and clinical performance sections, drafting responses to FDA.
• Conducted scientific reviews of product, communication, and marketing messaging.
• Developed and reviewed abstracts, publications, customer-facing materials, and presentations.

Austin, Texas, US

• Established and managed collaborative relationships with academic investigators and KOLs to enhance understanding of Natera’s ctDNA diagnostic platform and initiate research studies.
• Summarized scientific literature, abstracts, and clinical guidelines relevant to ctDNA product strategy and presented to executive leadership and cross-functional teams.
• Prepared research briefs, development plans, and scientific presentations for internal and external use.
• Served as a Core team member, presenting research collaboration pipeline and progress to internal teams.

Sunnyvale, California, US

• Evaluated scientific literature for clinical validity of gene-disease associations.
• Critically evaluated scientific evidence for direct-to-consumer genetic test report content.
• Identified candidate genetic health reports for future development.

San Diego, CA, US

• Populated database with genomic biomarkers and associated reports by critically analyzing medical genetics literature.
• Analyzed scientific literature to clinically validate over 150 predictive genomic biomarkers for the ASCO Targeted Agent and Profiling Utilization Registry (TAPUR) clinical trial study eligibility list.
• Curated clinical trials, FDA drug labels, and NCCN guidelines to identify clinically relevant variants for a genetic knowledge base.
• Mapped genomic variants to reference genome using IGV.
• Authored biomarker reports summarizing the clinical significance of somatic genetic variants, including relevant guideline recommendations and clinical study evidence.
• Utilized multiple databases, including COSMIC, clinicaltrials.gov, cBio Cancer Genomics Portal, Uniprot, and Pubmed.

Palo Alto, CA, US

Investigated the role of microRNA-126 in lung and breast cancer.

San Francisco, California, US

Conducted research on intestinal stem cell regulation, resulting in two first-authorship papers.

San Francisco, CA, US

• Prepared lab lectures and wrote weekly quizzes
• Graded scientific research papers

Doctor Of Philosophy (Phd), Pharmaceutical Sciences And Pharmacogenomics

Bachelor Of Science (Bs), Biochemistry